ABT-202

Source: Wikipedia, the free encyclopedia.
ABT-202
Identifiers
  • (R)-1-(Pyridin-3-yl)pyrrolidin-3-amine
JSmol)
  • N[C@@H]1CCN(C2=CC=CN=C2)C1
  • InChI=1S/C9H13N3/c10-8-3-5-12(7-8)9-2-1-4-11-6-9/h1-2,4,6,8H,3,5,7,10H2/t8-/m1/s1 ☒N
  • Key:LVGMMVAWLISWJD-MRVPVSSYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

ABT-202 is a drug developed by

clinical trials.[1][2][3]

References

  1. PMID 14983978
    .
  2. S2CID 34763474
    .
  3. PMID 15351065
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=ABT-202&oldid=1205243169"